The Livingston Awards are handed out every year to celebrate outstanding work from journalists under 35. Here are this year’s winning stories, honored this week in New York: “Slavery’s Last Stronghold” (John D. Sutter & Edythe McNamee, CNN.com) International Reporting winner: A trip to Mauritania, where an estimated 10% to 20% of the population lives in slavery. […]
Search results
Posted inMember Pick, Nonfiction, Story
‘My Body Stopped Speaking to Me’: The First-Person Account of a Near-Death Experience
Our recent Longreads Member Pick by National Magazine Award winner Andrew Corsello from GQ is now free for everyone. Special thanks to our Longreads Members for helping bring these stories to you—if you’re not a member, join us here. “My Body Stopped Speaking to Me,” is a personal story about Corsello’s near-death experience, first published […]
Posted inUncategorized
Reading List: A Bizarre Institution
Emily Perper is a freelance editor and reporter, currently completing a service year in Baltimore with the Episcopal Service Corps. What do Scientology, child abuse, financial exploitation, and millionaire parents have in common? They’ve all got a niche in the education system. 1. “Surviving a For-Profit School.” (Stephen S. Mills, The Rumpus, July 2013) A […]
Posted inUncategorized
Playlist: 5 Podcast Episodes on the History of Hip-Hop
Gabrielle Gantz (@contextual_life) is the blogger behind The Contextual Life, a frequent longreader, and a fan of podcasts. 1. How Hip-Hop Works (Stuff You Should Know, 52:13) In this episode of Stuff You Should Know, hosts Chuck and Josh discuss the history of hip-hop, from The Sugar Hill Gang to the present. They add their own […]
Posted inBooks, Member Pick, Nonfiction, Story
‘Quebrado’: The Life and Death of a Young Activist
“If you survive me, tell them this: I never gave up.”
Posted inUncategorized
“In the jargon of economics, the demand for therapeutic drugs is ‘price inelastic’: increasing the price doesn’t reduce how much the drugs are used. Prices are set and raised according to what the market will bear, and the parties who actually pay the drug companies will meet whatever price is charged for an effective drug […]
